Le Lézard
Classified in: Health, Science and technology
Subject: PDT

CEFALY Technology Launches Headaches.com Resource for Neuromodulation Migraine Treatment


DARIEN, Conn., June 4, 2024 /PRNewswire/ -- Medical device maker CEFALY Technology today launched Headaches.com to help healthcare providers and migraine patients learn about non-invasive neuromodulation as an innovative and effective treatment for migraine. 

An estimated 1 billion people worldwide live with migraine, which is a complex and debilitating neurological disorder. Migraine is most commonly characterized by an intense pulsing or throbbing headache on one side of the head, but also involves other symptoms such as nausea, vomiting, and sensitivity to light and sound. 

Despite migraine's prevalence, the condition is often misunderstood, underdiagnosed, and ineffectively treated. Headaches.com seeks to educate medical professionals and people with migraine about the mechanisms and benefits of neuromodulation for migraine.

On Headaches.com, users will find: 

External trigeminal nerve stimulation (eTNS) is a type of neuromodulation therapy that uses tiny, precise electrical impulses to directly target and modulate the activity of the trigeminal nerve, the primary pathway for migraine pain. Research has shown that eTNS both relieves active migraine attacks (acute therapy) and prevents future migraine attacks (preventative therapy). CEFALY is the best-known eTNS device and the only FDA-cleared device used for the treatment and prevention of migraine that is available without a prescription.

"For 15 years, CEFALY has provided a safe and effective treatment option for migraine, without the disabling side effects of medication," said Jen Trainor McDermott, CEO of CEFALY Technology. "With the launch of Headaches.com, we hope to educate healthcare providers about the benefits of neuromodulation for migraine and empower millions of people with migraine to add neuromodulation to their treatment regimen."

About the CEFALY device:

CEFALY Technology is the maker of CEFALY, an FDA-cleared, over-the-counter wearable medical device clinically proven to help reduce migraine frequency and relieve migraine pain. CEFALY is a non-invasive device placed on the forehead to modify pain sensation in the area research identifies as a center for migraine pain, the trigeminal nerve. 

The Bluetooth-enabled CEFALY Connected syncs with the CeCe Migraine Management app and enables users to track CEFALY treatments and log migraine attacks on their mobile device. With these insights, they can better understand their migraine patterns and optimize their treatments.

About CEFALY Technology:

CEFALY Technology is a Belgium-based company with U.S. offices based in Darien, Conn., specializing in electronics for medical applications. CEFALY Technology's mission is to provide innovative, ever-evolving technology that enables people with migraine to take control of their treatment and live happier, healthier lives.

Learn more about CEFALY by visiting www.CEFALY.com and following us on Facebook, Twitter, LinkedIn, Instagram and TikTok.

Media Contact:
CEFALY
Jen Trainor McDermott
CEO
[email protected]

SOURCE CEFALY Technology


These press releases may also interest you

at 20:07
Ascentage Pharma Received US$100 Million Option Payment from Takeda
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:00
Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

at 19:54
British Columbia designates Psychotherapy under the Health Professions Act
On July 02, 2024, the BC Government designated Psychotherapy as a Health Profession under the Health Professions Act. The proposal received cabinet approval and was subsequently signed by the Lieutenant Governor. The official order can be viewed...

at 19:52
Whitman-Walker Institute Condemns Nationwide Injunction Blocking Federal Nondiscrimination Protections for Transgender People Following a 'Shameful' Decision in Tennessee Case
Whitman-Walker Institute condemns the politically motivated ruling from a federal district court judge that blocks vital nondiscrimination protections for transgender people across the country. Today, a U.S. district court judge in Mississippi issued...

at 19:22
Baixiang brand Instant Noodles recalled due to undeclared peanut
Product: Instant Noodle Issue: Food - Allergen - Peanut Distribution: AlbertaBritish ColumbiaOntario See the affected products and product photos for this recall Company information Five Continents International Ltd. Telephone: 416-292-6766| Fax:...

at 18:45
Samaritan's Purse Airlifts Relief Supplies to Hurricane-Battered Grenada
The Samaritan's Purse DC-8 departed our hangar in Greensboro, North Carolina, yesterday morning, with a 13-member Disaster Assistance Response Team (DART) and 24 tons of life-saving relief for hurricane-devastated residents of Grenada in the south...

More news about Health...


News published on and distributed by: